STAIR Grant Archives - Venture Catalyst

Technology Commercialization Proof-of -Concept Grants Available

February 3, 2021/in News /by Karina Saravia-Butler

VENTURE CATALYST PROOF-OF-CONCEPT PROGRAMS

Venture Catalyst manages three proof-of-concept programs, which provide funding and resources to translate basic UC Davis research with commercial potential by demonstrating proof-of-concept and establishing market viability. These programs also help develop an innovative and entrepreneurial culture that extends the benefits of UC Davis research activities beyond the boundaries of the university.

Science Translation & Innovative Research (STAIR™) Grant
Food Systems Innovation Grant
Data, Informatics & Application Launch (DIAL™) Grant

Key features of the proof-of-concept programs include:

targeted funding to bridge the gap between basic research and early-stage commercialization efforts,
project work conducted over a 12-month period,
Review Committee consisting of industry representatives with corporate, investor, and entrepreneurial expertise,
feedback and guidance on commercialization from members of the Review Committee and the Venture Catalyst team, and
structured entrepreneurial training.

Over the past seven cycles, the proof-of-concept programs have awarded over $2.2 million of funding to 49 projects. These projects have resulted in 22 intellectual property agreements, including 16 startups launched around foundational technologies, and have been able to attract roughly $33 million of follow-on funding. See the list of previous awardees here and view the executive summary for the 2019-20 cycle here.

Venture Catalyst will begin accepting application for the eighth cycle of the proof-of-concept programs on January 19, 2021 with an application deadline of March 3, 2021 at 5:00 pm PST. Applications for all proof-of-concept programs can be submitted through Office of Research’s InfoReady grant application platform (Kerberos login required). The direct links to each grant are as follows:

Potential applicants can view a recorded information session for the 2020-21 cycle. If you would like to request an overview presentation and/or a Q&A session for your department or unit, please email [email protected].

For the STAIR and DIAL Grant programs, Venture Catalyst has engaged campus and industry partners to expand potential funding available to particular technologies and projects through the program. Partners include Elanco, the UC Davis College of Biological Sciences, the UC Davis College of Letters & Science, the UC Davis School of Medicine, and the UC Davis School of Veterinary Medicine. See additional details on types of funding and areas of interest in the program materials below.

Aspect

Technology Focus

IP Consideration

Project Budget

Funding Available for 2020-21 Cycle

Download Program Materials for 2020-21 Cycle

STAIR Grant

Broad

Patent potential

Up to $50,000

$250,000*

STAIR Grant Program Announcement

STAIR Grant RFP

STAIR Grant Application Form

STAIR Grant Application Instructions

Funding Partner Information

STAIR Grant Invitation to Self-Identify Form

Food Systems Innovation Grant

Global nutrition and food systems

Patent potential

Up to $50,000

$50,000**

Food Systems Innovation Grant Program Announcement

Food Systems Innovation Grant RFP

Food Systems Innovation Grant Application Form

Food Systems Grant Application Instructions

Food Systems Innovation Grant Invitation to Self-Identify Form

DIAL Grant

Data, information science, and software

Copyright or patent potential

Up to $20,000

$40,000

DIAL Grant Program Announcement

DIAL Grant RFP

DIAL Grant Application Form

DIAL Grant Application Instructions

Funding Partner Information

DIAL Grant Invitation to Self-Identify Form

*Supplemental funding available from campus and industry partners
**All eligible Food Systems Innovation Grant applicants will also be reviewed through the STAIR Grant program

Email questions about any of the proof-of-concept grant programs to [email protected].

UC Davis STAIR Grant Awards Over $400K to Advance Innovations Towards Commercialization

June 14, 2019/in News /by Aj Cheline

Jamie Peyton, chief of integrated medicine at the UC Davis School of Veterinary Medicine, fits a biologic bandages made from tilapia skin onto the badly burned paws of a bear. Peyton and her team have developed a tilapia skin xenograft for use in burn patients to alleviate pain and encourage rapid healing. (UC Davis)

Original post: research.ucdavis.edu/2019-stair-grants

DAVIS, Calif. — Innovators at the University of California, Davis, are receiving financial support to advance their research and technologies toward commercialization.

The Science Translation and Innovative Research (STAIR™) Grant program, managed by Venture Catalyst and funded by the UC Davis Office of Research, provides funding to support translational science and innovative research performed by UC Davis researchers. The goal of the program is to demonstrate early proof-of-concept and commercial potential or feasibility for technologies being developed with the intent of commercial translation.

Award recipients this year include campus investigators developing technologies that could have a significant impact on pressing human and animal health issues as well as creating efficiencies to nourish and feed the world.

“It is exciting to see how the award recipients are addressing a wide range of unmet challenges in nutrition and health,” said Prasant Mohapatra, vice chancellor for research at UC Davis. “With the STAIR Grant program, we are able to support the creativity and ingenuity of our researchers in these programs to translate their innovations into commercial applications that help bolster our economy and improve quality of life.”

Request For Proposals: STAIR™ Grant Funding to Support Translational Science and Innovative Research

January 22, 2019/in News /by Aj Cheline

The UC Davis Science Translation and Innovative Research (STAIR) Grant Program, now in its second year (FY 2014-2015), is managed by the Venture Catalyst unit and funded by the Office of Research.

The objective of the program is to provide targeted funding to support translational science and innovative research performed by UC Davis researchers, with the intent of demonstrating early proof-of-concept and commercial potential and/or feasibility for technologies being developed at UC Davis for potential commercial translation. Examples of outcomes that might be realized from availability of such research results include: development of research or commercial prototypes; generation of translational data that would not have been funded by traditional research grants; patent claims enablement; and enablement of more competitive SBIR/STTR grant applications by a subsequent startup that benefits from license rights to the underlying technologies.

The program seeks to stimulate entrepreneurial engagement by university researchers with potential for local and
regional economic impact.

Download full program overview >

TechAccel Makes Further Pledge to the UC Davis Venture Catalyst STAIR Grant Program to Promote Agriculture

March 7, 2018/in News /by Aj Cheline

TechAccel will commit $50,000 in grant funding to an expansion of the Venture Catalyst STAIR grants, which are in their fifth year of enabling the commercial translation of UC Davis research and technologies through proof-of-concept funding.

This promise of additional funding is intended to elicit more agricultural-focused technologies. TechAccel’s additional funding will support a sixth STAIR grant this year to focus exclusively on a technology in plant or animal agriculture, animal health, animal nutrition, or technologies to reduce post-harvest food waste and increase food safety. If successful, this expanded program may be repeated.

Applications for program funding are now available to UC Davis researchers. The deadline is March 12, 2018.

“We are proud to collaborate with the world-class talent at UC Davis,” said Michael Helmstetter, Ph.D., President and CEO of TechAccel. “Together, we see opportunities to make a greener, healthier future by helping advance agriculture, animal health, and food safety technologies to market.”

Dushyant Pathak, associate vice chancellor for Research and executive director of Venture Catalyst at UC Davis, agreed.

“We’re thrilled with this generous enhancement to our existing collaboration with TechAccel which has already provided support for novel translational research at the university,” he said. “TechAccel’s unique focus and its combination of business and technical expertise provide the perfect complement to our strengths at UC Davis in technology development and product innovation for societal impact.”

TechAccel is a technology and venture development organization focused in agriculture, animal health and food technology. The company invests in innovative technology and funds science advancement programs to accelerate readiness for commercialization.

TechAccel began its collaboration with UC-Davis in 2016 with participation in the UC-Davis Venture Catalyst STAIR-Plus^TMprogram, which supports STAIR^TM grant recipients who successfully achieve their commercialization milestones.

As part of the program, TechAccel executives participate in the review and assessment of grant applications in agriculture, animal health, food and nutrition. TechAccel executives provide mentorship to grant-winning researchers, who may also be considered for future TechAccel emerging company investments.

TechAccel also recently announced an investment in a science advancement project underway at The Siegel Lab in the Genome Center at UC Davis. This project, led by Justin B. Siegel, Ph.D., Faculty Director of the Innovation Institute for Food and Health, Assistant Professor of Chemistry, Biochemistry & Molecular Medicine at UC Davis, is directed towards identifying mutations in a wheat enzyme can produce plants capable of thriving in warmer temperatures.

About TechAccel

TechAccel LLC was founded in 2014 as a first-of-its-kind technology and venture development company in the agriculture, animal health and food technology sectors. TechAccel sources, invests in and acquires early-stage innovations. Through collaborations with universities and research institutions, TechAccel conducts advancement and de-risking research and development to ready technologies for commercialization. For more information, visit www.techaccel.net. Follow us on Twitter at @Tech_Accel.

About UC Davis

UC Davis is a global community of individuals united to better humanity and our natural world while seeking solutions to some of our most pressing challenges. Located near the California state capital, UC Davis has more than 35,000 students, an annual research budget of over $780 million and a comprehensive health system. The university offers 102 undergraduate majors and 99 graduate programs through four colleges and six professional schools.

About Venture Catalyst

Venture Catalyst is one of three units within the Technology Management & Corporate Relations division of the UC Davis Office of Research. Venture Catalyst furthers the university’s educational, research and public mission by supporting UC Davis students, faculty and researchers in translating science, engineering and innovative research, through well-resourced startups, into societal impact.

Media Contacts:

UC Davis

AJ Cheline

530.219.8739

[email protected]

UC Davis Venture Catalyst Expands Program to Accelerate Technology Commercialization with STAIR-Plus Grants — Announces Recipients

August 2, 2017/in News /by Aj Cheline

To support campus innovators in advancing their cutting-edge technologies towards commercialization, Venture Catalyst –within the Technology Management and Corporate Relations division of the UC Davis Office of Research – has offered Science Translation and Innovative Research (STAIR^TM) Grants for the last four years. The unique STAIR Grant program provides funding and support to help innovators demonstrate proof-of-concept and commercial feasibility for their technologies. To date, a total of $897,000 has been awarded to 19 faculty members as part of this program.

This year, Venture Catalyst announced the addition of the STAIR-Plus™ Grant program, intended to offer additional support to STAIR Grant recipients who have successfully achieved their projected commercialization milestones and are poised for commercial impact pending completion of specific targeted activities. Each recipient receives up to $20,000 in funding to be deployed over a one year period. Funding for the STAIR-Plus program was made possible by the State of California’s Assembly Bill 2664, which was passed in late 2016.

2017 STAIR-Plus Grant Recipients

Gino Cortopassi, professor, Department of Molecular Biosciences

Transition to patentable New Chemical Entity Shc inhibitors for Fatty Liver Disease

Cortopassi and his team have identified several compounds that inhibit Shc, a signaling protein that regulates the body’s response to insulin and resistance to pediatric nonalcoholic fatty liver disease. With assistance from the STAIR grant, the team conducted medicinal chemistry optimization to narrow dozens of functional parent molecules down to several of the most productive candidates. The STAIR-Plus Grant will allow the team to conduct additional screening and test the two most potent inhibitors in-vivo in an animal model.

Tony Simon, professor, Department of Psychiatry and Behavioral Sciences

Translation of Neurotherapeutic Video Games to Virtual Reality

Simon has invented a “neurotherapeutic” video game designed to help improve the cognitive abilities of children with one of several genetic disorders, the healthy aging and patients with many forms of Traumatic Brain Injury or Stroke. The STAIR Grant enabled Simon and his team to build prototypes utilizing desktop computers and game consoles which were used to conduct tests to provide evidence of clinical benefit. Simon plans to use funding from the STAIR-Plus Grant to develop, with his game design partner, a second generation prototype utilizing a virtual reality platform and to conduct preliminary tests for usability and efficacy potential.

John Voss, professor, Department of Biochemistry and Molecular Medicine

A novel nitroxide-based agent to produce contrast enhancement

for amyloid beta peptide detection by MRI

Voss’s team is developing technology based on a small molecule with potential for the early detection of Alzheimer’s disease. The compound is innovative for its paramagnetic properties, which affect MRI intensities correlating to an early and prominent marker for Alzheimer’s. Unlike available imaging methods, this approach would be less expensive, enable greater patient access and eliminate radiation exposure for the patient. Voss utilized the STAIR Grant to conduct in vivo tests to demonstrate effectiveness and to synthesize nine novel small molecules. Voss plans to use the STAIR-Plus Grant to conduct additional optimization leading to the selection of a lead candidate. He also plans to use high resolution imaging to better correlate the contrast signal with identifiable brain structures.

Each application was reviewed by the STAIR-Plus Grant Review Committee, which included Office of Research staff and external industry reviewers with specific domain expertise. The Review Committee considered the technical merit, commercial potential, outcomes from previous STAIR Grant milestones, and alignment of budget with projected activities for each project.

”I’m thrilled that the California legislature’s investment in innovation and entrepreneurship at the university is enabling us to extend the bridge between cutting-edge research and its potential for transformative human impact,” said Dushyant Pathak, associate vice chancellor of Research and executive director of Venture Catalyst. ”These funds, in addition to the prior investment by the university through our STAIR grants, are accelerating the commercialization of new technologies from UC Davis.”

An important component of the STAIR-Plus program is the engagement of award recipients with additional entrepreneurial and technology commercialization support and resources through a unique collaboration between Venture Catalyst and the Mike and Renee Child Institute for Innovation and Entrepreneurship at UC Davis. Award recipients will participate in a cohort-based series of innovation and commercialization clinics designed to develop the skills and networks needed to explore and expand the commercial potential and resulting societal impact of their ideas.

These highly customized business clinics will include engagement with industry experts and mentors to supplement the workshops, which will be focused on commercialization elements including market and business model validation and coaching for effective business communication.

“We’re honored to help such talented innovators from across our campus to commercialize their work and ensure that the benefits of their research move from the lab and out into the world,” said Cleveland Justis, the institute’s executive director.

AB 2664 Spurs Innovation and Entrepreneurship

Assembly Bill 2664, also referred to as the Innovation and Entrepreneurship Expansion bill, was authored by Assembly member Jacqui Irwin, D-Thousand Oaks, and signed last fall by Governor Jerry Brown. AB 2664 is designed to propel new innovation and entrepreneurship efforts across the University of California through investments in infrastructure, incubators and entrepreneurship education programs. The $22 million investment was dispersed equally to each of the ten UC campuses at the beginning of 2017. Venture Catalyst is the program lead at UC Davis and is implementing a variety of innovation and entrepreneurship expansion activities in conjunction with partners on campus, including the Mike and Renee Child Institute for Innovation & Entrepreneurship, the Engineering Student Startup Center, the Office of the Provost, Graduate Studies and the Internship and Career Center, as well as external community partners.

Media Contacts

AJ Cheline (530)219-8739

Links

• STAIR grant program
• “Digital neurotherapeutic” game in development at the UC Davis MIND Institute

Nine grants, totaling $328,000, awarded to help campus innovators advance research and technology towards commercialization

June 27, 2017/in News /by Aj Cheline

UC Davis announced today the recipients of nine proof-of-concept grants totaling $328,000 for campus innovators to advance their research and technologies towards commercialization. These grants and the associated review process are managed by UC Davis Venture Catalyst through the Science Translation and Innovative Research (STAIR^TM) grant program, which is in its fourth year, and the newly launched Data, Informatics and Application Launch (DIAL^TM) grant program.

“It remains the responsibility of public universities like UC Davis, to fulfil their societal mission of generating impact from research, by facilitating the translation of faculty and student research into meaningful products and services that enrich the human experience,” said Dushyant Pathak, associate vice chancellor for research and executive director of Venture Catalyst at UC Davis. “Through our successful STAIR grant program and the newly launched DIAL grants, we are enabling our most innovative campus researchers to map a more effective path from their scientific and engineering breakthroughs to the commercial sphere.”

The 2017 STAIR grant recipients

The STAIR grant program provides awards of up to $50,000 per grant recipient to help campus innovators demonstrate proof-of-concept and commercial feasibility of their technologies. A total of 30 applications were received this year. Six award recipients were selected to receive grants following a multistage review process involving external industry experts, investors and entrepreneurs that evaluated each application based on its market potential, technical merit and ability to achieve identified commercialization milestones with the funds requested.

This year’s STAIR grant recipients are:

Johnathon Anderson, assistant professor, Stem Cell Research Program

Anderson and his team have developed a novel drug candidate platform for inflammatory diseases that offers the beneficial aspects of stem cell therapeutics with fewer hurdles to clinical development.

Paul Henderson, associate adjunct professor, Department of Internal Medicine

Henderson and his team are developing an add-on chemotherapy drug that increases the effectiveness of existing treatment regimens for advanced bladder cancer. Their innovation, an orally bioavailable drug, combines anti-inflammatory and anti-angiogenic properties.

Lee Miller, associate professor, Center for Mind and Brain

Miller and his team have developed a powerful electroencephalogram (EEG) diagnostic that provides a rapid and comprehensive assessment of the functional health of the auditory system, including how speech is processed at different levels and how these levels interact. Their innovation is expected to enable individualized assessments of hearing loss and improve the performance of assistive listening devices.

David Olson, assistant professor, Department of Chemistry

Olson and his team have discovered how to decouple the beneficial effects of neuroplasticity-promoting compounds from their deleterious hallucinogenic and psychostimulant effects in order to develop more effective drug therapies for various neurological disorders.

Lin Tian, assistant professor, Department of Biochemistry and Molecular Medicine

Tian and her team have developed a novel technology for drug discovery involving G-protein-coupled receptors (GPCRs). Their innovation directly tackles GPCR confrontational dynamics in living cells and organisms, providing a novel platform for rigorous high-throughput cell-based screening and validation.

Yu-Jui (Yvonne) Wan, vice chair for research, Department of Pathology and Laboratory Medicine

Wan and her team are developing a bio-encapsulation process using yeast to deliver retinoic acid and a short-chain fatty acid with histone deacetylase (HDAC) inhibitory properties that benefit the liver and intestine — offering the potential to help prevent and treat metabolic-associated diseases and cancer.

The 2017 DIAL grant recipients

The DIAL grant program is a pilot program structured similarly to the STAIR grant program, which targets commercial opportunities in software, informatics and data science. This program is enabled by funding provided by the State of California under Assembly Bill AB 2664. Passed in 2016, this unique legislation authorizes one-time funding of $2.2 million to each of the 10 University of California campuses with the objective of expanding innovation and entrepreneurship programs on each campus. Three DIAL grant recipients were selected following a review process modeled on the STAIR grant program, based on each project’s market potential, technical merit and ability to achieve identified commercialization milestones with the funds requested.

The DIAL grant award recipients are:

Petr Janata, professor, Department of Psychology

Janata has invented an online platform that allows users to document and share personal memories they associate with specific pieces of music. Janata’s technology platform leverages his research in the field of cognitive neuroscience and the psychology of music to enable a number of life enriching applications linking music, memory and interpersonal interactions.

Nelson Max, distinguished professor, Department of Computer Science

Max and his team have developed a novel system for use in emergency response training where emergency scenarios can be added to real world environments. His invention uses a quadcopter camera that will add computer-generated artificial reality graphic image components to a computer screen.

Lisa Miller, professor, Department of Human Ecology

Miller and her team have invented a gaming app to teach nutrition concepts, practice food-choice skills, build nutritional literacy and promote healthy behavior-change in adults to combat poor dietary habits.

Benefits extend beyond financial awards

In addition to the financial support, each recipient of STAIR and DIAL grants is assigned an experienced business mentor to review project milestones, offer commercialization guidance, provide business advice, and facilitate networking opportunities and connections to industry. Additionally, through a collaboration between Venture Catalyst and the UC Davis Mike and Renee Child Institute for Innovation & Entrepreneurship, and enabled by the State of California’s AB 2664 Innovation and Entrepreneurship expansion funding, STAIR and DIAL grant teams will participate in commercialization clinics that will provide them with business and commercialization guidance and skills development.

“The direct interface between grant recipients and experienced industry experts, along with accompanying cohort-based skills development and training, is a critical element of the success of these proof-of-concept grant programs in de-risking UC Davis technologies and moving them closer to commercial uptake and societal impact,” said Pathak. “We are proud of our close collaboration with the Institute for Innovation & Entrepreneurship and grateful to our external industry review panel and participants in the STAIR and DIAL mentor engagement programs.”

Future awards

The application process for next year’s STAIR grant will begin in early 2018 and will be open to anyone with principal investigator status at UC Davis. Postdoctoral scholars and staff are eligible to apply as co-principal investigators. The DIAL grant program offering in subsequent years is yet to be determined and will be announced as soon as a decision has been made.

Media contact

AJ Cheline, Office of Research, (530) 752-1101, [email protected]

From Ideas to Innovations: Recipients of 2016 STAIR Grants Announced

January 4, 2017/in News /by Aj Cheline

August 4, 2016: Venture Catalyst, a unit within the Technology Management and Corporate Relations division of the UC Davis Office of Research, is pleased to announce the recipients of the 2016 Science Translation and Innovative Research, or STAIR, grants.

Now in its third year, the competitive STAIR grant program provides awards of up to $50,000 to help campus entrepreneurs demonstrate proof-of-concept and commercial feasibility of their technologies.

This year’s award recipients are undertaking innovative projects to address a variety of unmet market needs. The 2016 STAIR award winners are:

Gino Cortopassi, professor, Department of Molecular Biosciences; Alexey Tomilov, assistant project scientist, Department of Molecular Biosciences
Cortopassi and Tomilov have identified several compounds that significantly inhibit Shc, a signaling protein that has been shown to improve the body’s response to insulin and produce resistance to pediatric nonalcoholic fatty liver disease.

Richard Levenson, professor and vice chair, Department of Pathology and Laboratory Medicine; Farzad Fereidouni, assistant project scientist, Department of Pathology and Laboratory Medicine
Levenson and his team have created an innovative new method for spectral imaging that drastically reduces the amount of data needed for analysis. Their novel approach uses a conventional camera sensor fitted with either a filter wheel or beam-splitting optics.

Kai Liu, professor, Department of Physics
Liu and his team invented a new method that creates stable skyrmion lattices at room temperature and in zero magnetic field, making them an excellent candidate for energy efficient data storage as well as other nanoelectronics applications.

Tony Simon, professor, Department of Psychiatry and Behavioral Sciences
Simon has invented a “neurotherapeutic” video game designed to help improve the cognitive abilities of children with genetic disorders such as chromosome 22q11.2 deletion, fragile X, Turner and Williams syndromes, among others.

“The STAIR grant program is unique in many ways,” said Dushyant Pathak, associate vice chancellor for research at UC Davis and executive director of Venture Catalyst. “The structured review process we have developed enables our independent reviewers to effectively assess proposals for technical merit, market need and the ability to effectively achieve commercial milestones. Additionally, this process allows us to provide detailed written feedback to all applicants, which makes the STAIR program part of a continuous improvement and learning process rather than simply a funding opportunity.”

Each STAIR award recipient, as well as all award finalists, are assigned one or more volunteer mentors who review project milestones, offer commercialization guidance, provide business advice, and facilitate networking opportunities and connections to industry. The mentors are selected from the UC Davis Venture Catalyst MentorNet™ program and represent a mix of industry professionals, entrepreneurs and investors. Members of the Venture Catalyst MentorNet also serve on the grant application review committee.

The annual STAIR grant program is open to anyone with principal investigator eligibility at UC Davis. Postdoctoral scholars and staff are eligible to apply as co-principal investigators.

Past STAIR Grant Recipients Make Progress with Innovations

Previous years’ STAIR grant recipients have made significant progress in moving projects forward along the path to commercialization.

Richard Levenson has received a STAIR grant two years in a row. In 2015, he proposed developing a prototype for a new type of microscopy instrumentation. Microscopy with Ultraviolet Surface Excitation, or MUSE, as the novel technology is called, permits the creation of diagnostic-quality images of tissue samples that are generated in minutes using LED light, and eliminates the need for the traditional time-consuming preparation of samples and glass slides.

Levenson credits his STAIR grant as being pivotal in funding the opto-mechanical design of the prototypes that he and his team are assembling which will soon ship to collaborators. “Without STAIR funding, we would not have had the resources to move forward as we have.”

In addition to the creation of the prototypes, two patents have been issued for the invention and a third patent application has been submitted and published. The team has also launched a startup company, MUSE Microscopy Inc.

Related Links

• STAIR grant program
• 2015 Recipients
• 2014 Recipients
• “Digital neurotherapeutic” game in development at the UC Davis MIND Institute
• Magnetic skyrmions at room temperature: New digital memory?

Posts